Le Lézard
Classified in: Business, Covid-19 virus
Subjects: EARNINGS, Photo/Multimedia, Conference Call, Webcast

AB InBev Reports Full Year and Fourth Quarter 2023 Results


AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD):

Regulated and inside information1

"Our business delivered another year of consistent profitable growth with a revenue increase of 7.8% and EBITDA growth of 7.0%. Strong free cash flow generation enabled us to progress on our deleveraging, propose an increased dividend to our shareholders and execute on a 1 billion USD share buyback. Our results are a testament to the strength of the beer category, resilience of our business and people, consistent execution of our replicable growth drivers and our unwavering commitment to invest for long-term growth and value creation." ? Michel Doukeris, CEO, AB InBev

Total Revenue

4Q +6.2% | FY + 7.8%

Revenue increased by 6.2% in 4Q23 with revenue per hl growth of 9.3% and by 7.8% in FY23 with revenue per hl growth of 9.9%.

 

24.6% increase in combined revenues of our global brands, Budweiser, Stella Artois, Corona and Michelob Ultra, outside of their respective home markets in 4Q23, and 18.2% in FY23.

 

Approximately 70% of our revenue through B2B digital platforms with the monthly active user base of BEES reaching 3.7 million users.

 

Over 550 million USD of revenue generated by our digital direct-to-consumer ecosystem.

 

Total Volume

4Q - 2.6% | FY - 1.7%

In 4Q23, total volumes declined by 2.6% , with own beer volumes down by 3.6% and non-beer volumes up by 3.0%. In FY23, total volumes declined by 1.7% with own beer volumes down by 2.3% and non-beer volumes up by 2.1%.

 

Normalized EBITDA

4Q + 6.2% | FY +7.0%

In 4Q23, normalized EBITDA increased by 6.2% to 4 877 million USD with a normalized EBITDA margin contraction of 2 bps to 33.7%. In FY23, normalized EBITDA increased by 7.0% to 19 976 million USD and normalized EBITDA margin contracted by 23 bps to 33.6% . Normalized EBITDA figures of FY23 and FY22 include an impact of 44 million USD and 201 million USD, respectively, from tax credits in Brazil.

Underlying Profit (million USD)

4Q 1 661 | FY 6 158

Underlying profit (profit attributable to equity holders of AB InBev excluding non-underlying items and the impact of hyperinflation) was 1 661 million USD in 4Q23 compared to 1 739 million USD in 4Q22 and was 6 158 million USD in FY23 compared to 6 093 million USD in FY22.

 

Underlying EPS (USD)

4Q 0.82 | FY 3.05

Underlying EPS was 0.82 USD in 4Q23, a decrease from 0.86 USD in 4Q22 and was 3.05 USD in FY23, an increase from 3.03 USD in FY22.

 

Net Debt to EBITDA

3.38x

Net debt to normalized EBITDA ratio was 3.38x at 31 December 2023, compared to 3.51x at 31 December 2022.

 

Capital Allocation

Dividend 0.82 EUR

The AB InBev Board proposes a full year 2023 dividend of 0.82 EUR per share, subject to shareholder approval at the AGM on 24 April 2024. A timeline showing the ex-dividend, record and payment dates can be found on page 16.

 

Out of the one billion USD share buyback program announced on 31 October 2023, 870 million USD was completed as of 23 February 2024.

The 2023 Full Year Financial Report is available on our website at www.ab-inbev.com.

1The enclosed information constitutes inside information as defined in Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse, and regulated information as defined in the Belgian Royal Decree of 14 November 2007 regarding the duties of issuers of financial instruments which have been admitted for trading on a regulated market. For important disclaimers and notes on the basis of preparation, please refer to page 17.

Management comments

Creating a future with more cheers

Our business delivered another year of consistent profitable growth, with an EBITDA increase of 7.0%, in-line with our medium-term growth ambition and outlook for the year. While our full growth potential was constrained by the performance of our US business, we remained true to our purpose and laser focused on the execution of our strategy.

We made disciplined revenue management and resource allocation choices, delivering broad-based growth with top- and bottom-line increases in four of our five operating regions. Our results are a testament to the strength of the beer category, resilience of our business and people, consistent execution of our replicable growth drivers and our unwavering commitment to invest for long-term growth and value creation.

As with any year, there was success to celebrate and challenges from which to learn. We are taking the learnings and moving forward in a stronger position to realize our full growth potential.

Delivering consistent profitable growth

Our top-line increased by 7.8% in FY23, with revenue growth in more than 85% of our markets, driven by a revenue per hl increase of 9.9% as a result of pricing actions, ongoing premiumization and other revenue management initiatives. Volumes declined by 1.7% as growth in many of our emerging and developing markets was primarily offset by performance in the US and a soft industry in Europe.

EBITDA increased by 7.0%, with our top-line growth partially offset by anticipated transactional FX and commodity cost headwinds and increased sales and marketing investments. Underlying EPS was 3.05 USD, an increase of 0.02 USD per share versus FY22.

Progressing our strategic priorities

Looking forward

As we reflect on 2023, while our full potential was constrained, the fundamental strengths of our business drove another year of consistent profitable growth. Beer is a large, profitable and growing category, gaining share of alcohol globally and with significant headroom for premiumization. Our diversified footprint, global scale and unparalleled ecosystem uniquely position us to lead and grow the category. We have replicable growth drivers such as our portfolio of megabrands that consumers love, digital products that unlock value and a category expansion model that drives organic growth. Our business generates superior profitability and cash generation, and our dynamic capital allocation framework provides us flexibility to maximize value creation. The resilience, relentless commitment and deep ownership culture of our people is truly unwavering, and we thank all our colleagues globally for their hard work and dedication.

Looking ahead to 2024, our purpose as a company remains as relevant as ever. Guided by our strategy and our focus on customer and consumer centricity, we are energized about the opportunities ahead to activate the category through our megabrands and platforms. We believe in the potential of the beer category, the fundamentals of our company and our people, and our ability to generate superior long-term value and create a future with more cheers.

2024 Outlook

(i) Overall Performance: We expect our EBITDA to grow in line with our medium-term outlook of between 4-8%1. The outlook for FY24 reflects our current assessment of inflation and other macroeconomic conditions.

(ii) Net Finance Costs: Net pension interest expenses and accretion expenses are expected to be in the range of 220 to 250 million USD per quarter, depending on currency and interest rate fluctuations. We expect the average gross debt coupon in FY24 to be approximately 4%.

(iii) Effective Tax Rates (ETR): We expect the normalized ETR in FY24 to be in the range of 27% to 29%. The ETR outlook does not consider the impact of potential future changes in legislation.

(iv) Net Capital Expenditure: We expect net capital expenditure of between 4.0 and 4.5 billion USD in FY24.

1Please refer to the FY24 presentation update on organic growth on page 16

Figure 1. Consolidated performance (million USD)

4Q22

4Q23

Organic

growth

Total Volumes (thousand hls)

148 775

144 706

-2.6%

AB InBev own beer

128 502

123 764

-3.6%

Non-beer volumes

19 421

19 998

3.0%

Third party products

853

944

13.1%

Revenue

14 668

14 473

6.2%

Gross profit

8 007

7 794

5.3%

Gross margin

54.6%

53.9%

-49 bps

Normalized EBITDA

4 947

4 877

6.2%

Normalized EBITDA margin

33.7%

33.7%

-2 bps

Normalized EBIT

3 608

3 491

6.9%

Normalized EBIT margin

24.6%

24.1%

16 bps

 

Profit attributable to equity holders of AB InBev

2 844

1 891

Underlying profit attributable to equity holders of AB InBev

1 739

1 661

 

Earnings per share (USD)

1.41

0.94

Underlying earnings per share (USD)

0.86

0.82

 

FY22

FY23

Organic

growth

Total Volumes (thousand hls)

595 133

584 728

-1.7%

AB InBev own beer

517 990

505 899

-2.3%

Non-beer volumes

73 241

74 810

2.1%

Third party products

3 903

4 019

4.7%

Revenue

57 786

59 380

7.8%

Gross profit

31 481

31 984

6.7%

Gross margin

54.5%

53.9%

-53 bps

Normalized EBITDA

19 843

19 976

7.0%

Normalized EBITDA margin

34.3%

33.6%

-23 bps

Normalized EBIT

14 768

14 590

6.4%

Normalized EBIT margin

25.6%

24.6%

-31 bps

 

Profit attributable to equity holders of AB InBev

5 969

5 341

Underlying profit attributable to equity holders of AB InBev

6 093

6 158

 

Earnings per share (USD)

2.97

2.65

Underlying earnings per share (USD)

3.03

3.05

 

Figure 2. Volumes (thousand hls)

4Q22

Scope

Organic

4Q23

Organic growth

growth

Total

Own beer

North America

23 451

- 149

-3 563

19 738

-15.3%

-16.2%

Middle Americas

38 286

-

348

38 635

0.9%

0.9%

South America

46 860

-

- 157

46 704

-0.3%

-2.0%

EMEA

24 094

50

- 180

23 964

-0.7%

-1.0%

Asia Pacific

15 903

-

- 438

15 465

-2.8%

-2.9%

Global Export and Holding Companies

181

-52

71

200

55.0%

54.8%

AB InBev Worldwide

148 775

- 151

-3 919

144 706

-2.6%

-3.6%

FY22

Scope

Organic

FY23

Organic growth

growth

Total

Own beer

North America

102 674

-118

-12 417

90 140

-12.1%

-12.6%

Middle Americas

147 624

-

1 106

148 730

0.7%

0.1%

South America

164 319

-

-1 859

162 460

-1.1%

-2.0%

EMEA

90 780

204

- 771

90 213

-0.8%

-1.1%

Asia Pacific

88 898

-

3 828

92 726

4.3%

4.2%

Global Export and Holding Companies

838

-236

-143

459

-23.7%

-26.4%

AB InBev Worldwide

595 133

- 151

-10 255

584 728

-1.7%

-2.3%

Key Market Performances

United States: Revenue declined by 9.5% impacted by volume performance

Mexico: High-single digit top- and bottom-line growth with margin expansion

Colombia: Record high volumes delivered double-digit top-line and high-single digit bottom-line growth

Brazil: High-single digit top-line and double-digit bottom-line growth with margin expansion of 462bps

Europe: High-single digit top- and low-single digit bottom-line growth

South Africa: Record high volumes delivered double digit top- and high-single digit bottom-line growth

China: Double digit top- and bottom-line growth with margin expansion of 125bps

Highlights from our other markets

Consolidated Income Statement

Figure 3. Consolidated income statement (million USD)

4Q22

4Q23

Organic

growth

Revenue

14 668

14 473

6.2%

Cost of sales

-6 661

-6 679

-7.4%

Gross profit

8 007

7 794

5.3%

SG&A

-4 592

-4 537

-4.3%

Other operating income/(expenses)

193

234

11.4%

Normalized profit from operations (normalized EBIT)

3 608

3 491

6.9%

Non-underlying items above EBIT (incl. impairment losses)

19

-165

Net finance income/(cost)

-1 221

-1 290

Non-underlying net finance income/(cost)

798

550

Share of results of associates

89

95

Non-underlying share of results of associates

-

-35

Income tax expense

5

-376

Profit

3 298

2 270

Profit attributable to non-controlling interest

454

379

Profit attributable to equity holders of AB InBev

2 844

1 891

 

Normalized EBITDA

4 947

4 877

6.2%

Underlying profit attributable to equity holders of AB InBev

1 739

1 661

 

FY22

FY23

Organic

growth

Revenue

57 786

59 380

7.8%

Cost of sales

-26 305

-27 396

-9.0%

Gross profit

31 481

31 984

6.7%

SG&A

-17 555

-18 172

-7.4%

Other operating income/(expenses)

841

778

19.8%

Normalized profit from operations (normalized EBIT)

14 768

14 590

6.4%

Non-underlying items above EBIT (incl. impairment losses)

-251

-624

Net finance income/(cost)

-4 978

-5 033

Non-underlying net finance income/(cost)

829

-69

Share of results of associates

299

295

Non-underlying share of results of associates

-1 143

- 35

Income tax expense

-1 928

-2 234

Profit

7 597

6 891

Profit attributable to non-controlling interest

1 628

1 550

Profit attributable to equity holders of AB InBev

5 969

5 341

 

Normalized EBITDA

19 843

19 976

7.0%

Underlying profit attributable to equity holders of AB InBev

6 093

6 158

 

We are reporting our Argentinean operation applying hyperinflation accounting under IAS 29, following the categorization of Argentina as a country with a three-year cumulative inflation rate greater than 100%, since 2018. Inflation in Argentina has accelerated, resulting in a more significant impact on the organic revenue growth of AB InBev than historically. For illustrative purposes, fully excluding the Argentinean operation, the 4Q23 organic revenue increase for AB InBev would be 0.5% versus the 6.2% reported. For FY23, revenue growth for AB InBev would be 3.8% versus the 7.8% reported.

Consolidated other operating income/(expenses) in FY23 increased by 19.8% primarily driven by higher government grants. In FY23, Ambev recognized 44 million USD income in other operating income related to tax credits (FY22: 201 million USD). The year-over-year change is presented as a scope change and does not affect the presented organic growth rates.

Non-underlying items above EBIT & Non-underlying share of results of associates

Figure 4. Non-underlying items above EBIT & Non-underlying share of results of associates (million USD)

4Q22

4Q23

FY22

FY23

COVID-19 costs

-2

-

-18

-

Restructuring

-47

-64

-110

-142

Business and asset disposal (incl. impairment losses)

72

-23

-71

-385

Claims and legal costs

-

-66

-

-85

AB InBev Efes related costs

-3

-12

-51

-12

Acquisition costs / Business combinations

-1

-

-1

-

Non-underlying items in EBIT

19

-165

-251

-624

Non-underlying share of results of associates

-

- 35

-1 143

- 35

EBIT excludes negative non-underlying items of 165 million USD in 4Q23 and 624 million USD in FY23. Business and asset disposal (including impairment losses) for FY23 includes a loss of approximately 300 million USD recognized upon disposal of a portfolio of eight beer and beverage brands and associated assets in the US to Tilray Brands, Inc in 3Q23.

Non-underlying share of results of associates of FY22 includes the non-cash impairment of 1 143 million USD the company recorded on its investment in AB InBev Efes in 1Q22.

Net finance income/(cost)

Figure 5. Net finance income/(cost) (million USD)

4Q22

4Q23

FY22

FY23

Net interest expense

-785

-712

-3 294

-3 131

Net interest on net defined benefit liabilities

-18

-26

-73

-90

Accretion expense

-231

-228

-782

-808

Net interest income on Brazilian tax credits

22

61

168

168

Other financial results

-208

-385

-997

-1 172

Net finance income/(cost)

-1 221

-1 290

-4 978

-5 033

Other financial results were negatively impacted by 125 million USD in 4Q23 versus 4Q22 and by 269 million USD in FY23 versus FY22, due to a decrease in hyperinflation monetary adjustments resulting from the devaluation of the Argentinean Peso in December 2023.

Non-underlying net finance income/(cost)

Figure 6. Non-underlying net finance income/(cost) (million USD)

4Q22

4Q23

FY22

FY23

Mark-to-market

454

294

606

-325

Gain/(loss) on bond redemption and other

344

256

223

256

Non-underlying net finance income/(cost)

798

550

829

-69

 

Non-underlying net finance cost in FY23 includes mark-to-market losses on derivative instruments entered into to hedge our shared-based payment programs and shares issued in relation to the combination with Grupo Modelo and SAB.

The number of shares covered by the hedging of our share-based payment program, the deferred share instrument and the restricted shares are shown in figure 7, together with the opening and closing share prices.

Figure 7. Non-underlying equity derivative instruments

4Q22

4Q23

FY22

FY23

Share price at the start of the period (Euro)

46.75

52.51

53.17

56.27

Share price at the end of the period (Euro)

56.27

58.42

56.27

58.42

Number of equity derivative instruments at the end of the period (millions)

100.5

100.5

100.5

100.5

 

Income tax expense

Figure 8. Income tax expense (million USD)

4Q22

4Q23

FY22

FY23

Income tax expense

-5

376

1 928

2 234

Effective tax rate

-0.2%

14.5%

18.6%

25.2%

Normalized effective tax rate

12.2%

16.7%

23.8%

24.3%

The increase in normalized ETR in 4Q23 compared to 4Q22 and the increase in FY23 compared to FY22 is driven mainly by country mix.

Figure 9. Underlying Profit attributable to equity holders of AB InBev (million USD)

4Q22

4Q23

FY22

FY23

Profit attributable to equity holders of AB InBev

2 844

1 891

5 969

5 341

Net impact of non-underlying items on profit

-1 127

-360

153

614

Hyperinflation impacts in underlying profit

22

130

- 30

203

Underlying profit attributable to equity holders of AB InBev

1 739

1 661

6 093

6 158

Underlying profit attributable to equity holders in 4Q22 and FY22 were positively impacted by 13 million USD and 186 million USD respectively, and in 4Q23 and FY23 by 55 million USD and 122 million USD respectively, after tax and non-controlling interest related to tax credits in Brazil.

Basic and underlying EPS

Figure 10. Earnings per share (USD)

4Q22

4Q23

FY22

FY23

Basic EPS

1.41

0.94

2.97

2.65

Net impact of non-underlying items on profit

-0.57

-0.18

0.07

0.31

Hyperinflation impacts in EPS

0.01

0.06

-0.02

0.10

Underlying EPS

0.86

0.82

3.03

3.05

Weighted average number of ordinary and restricted shares (million)

2 013

2 016

2 013

2 016

Figure 11. Key components - Underlying EPS in USD

4Q22

4Q23

FY22

FY23

Normalized EBIT before hyperinflation

1.83

1.86

7.41

7.42

Hyperinflation impacts in normalized EBIT

-0.04

-0.13

-0.07

-0.18

Normalized EBIT

1.79

1.73

7.34

7.24

Net finance cost

-0.61

-0.64

-2.47

-2.50

Income tax expense

-0.14

-0.18

-1.16

-1.15

Associates & non-controlling interest

-0.19

-0.15

-0.67

-0.64

Hyperinflation impacts in EPS

0.01

0.06

-0.02

0.10

Underlying EPS

0.86

0.82

3.03

3.05

Weighted average number of ordinary and restricted shares (million)

2 013

2 016

2 013

2 016

Reconciliation between normalized EBITDA and profit attributable to equity holders

Figure 12. Reconciliation of normalized EBITDA to profit attributable to equity holders of AB InBev (million USD)

4Q22

4Q23

FY22

FY23

Profit attributable to equity holders of AB InBev

2 844

1 891

5 969

5 341

Non-controlling interests

454

379

1 628

1 550

Profit

3 298

2 270

7 597

6 891

Income tax expense

-5

376

1 928

2 234

Share of result of associates

-89

-95

-299

-295

Non-underlying share of results of associates

-

35

1 143

35

Net finance (income)/cost

1 221

1 290

4 978

5 033

Non-underlying net finance (income)/cost

-798

-550

-829

69

Non-underlying items above EBIT (incl. impairment losses)

-19

165

251

624

Normalized EBIT

3 608

3 491

14 768

14 590

Depreciation, amortization and impairment

1 338

1 386

5 074

5 385

Normalized EBITDA

4 947

4 877

19 843

19 976

Normalized EBITDA and normalized EBIT are measures utilized by AB InBev to demonstrate the company's underlying performance.

Normalized EBITDA is calculated excluding the following effects from profit attributable to equity holders of AB InBev: (i) non-controlling interest; (ii) income tax expense; (iii) share of results of associates; (iv) non-underlying share of results of associates; (v) net finance income or cost; (vi) non-underlying net finance income or cost; (vii) non-underlying items above EBIT; and (viii) depreciation, amortization and impairment.

Normalized EBITDA and normalized EBIT are not accounting measures under IFRS accounting and should not be considered as an alternative to profit attributable to equity holders as a measure of operational performance, or an alternative to cash flow as a measure of liquidity. Normalized EBITDA and normalized EBIT do not have a standard calculation method and AB InBev's definition of normalized EBITDA and normalized EBIT may not be comparable to that of other companies.

Argentinean Peso devaluation

In December 2023, the Argentinean Peso underwent a significant devaluation with the USDARS exchange rate closing at 809 on 31 December 2023 compared to 350 on 30 September 2023. IFRS (IAS 29) require us to restate the year-to-date results for the change in the general purchasing power of the local currency, using official indices before converting the local amounts at the closing rate of the period (i.e. FY23 and FY22 results at the closing rate on 31 December 2023 and 2022, respectively). The December 2023 devaluation negatively impacted our revenue and Normalized EBITDA as reported in 4Q23 and FY23. The impact of hyperinflation accounting in 4Q22 and 4Q23, as well as FY22 and FY23 were as follows:

Impact of hyperinflation (million USD)

Revenue

4Q22

4Q23

FY22

FY23

Indexing (1)

161

156

483

561

Currency(2)

-268

-855

-578

-1 279

Total impact

-107

-699

-95

-717

 

Normalized EBITDA

4Q22

4Q23

FY22

FY23

Indexing (1)

41

83

150

211

Currency(2)

-107

-356

-209

-525

Total impact

-66

-274

-59

-314

 

USDARS average rate

128

294

USDARS closing rate

177

809

(1)

Indexation calculated at closing rate

(2)

Currency impact from hyperinflation calculated as the difference between converting the Argentinean peso (ARS) reported amounts at the closing exchange rate compared to the average exchange rate of each period

Financial position

Figure 13. Cash Flow Statement (million USD)

FY22

FY23

Operating activities

Profit of the period

7 597

6 891

Interest, taxes and non-cash items included in profit

12 344

14 181

Cash flow from operating activities before changes in working capital and use of provisions

19 941

21 072

 

Change in working capital

- 346

-1 541

Pension contributions and use of provisions

- 351

- 419

Interest and taxes (paid)/received

-6 104

-5 975

Dividends received

158

127

Cash flow from/(used in) operating activities

13 298

13 265

 

Investing activities

Net capex

-4 838

-4 482

Sale/(acquisition) of subsidiaries, net of cash disposed/ acquired of

- 70

9

Net proceeds from sale/(acquisition) of other assets

288

119

Cash flow from/(used in) investing activities

-4 620

-4 354

 

Financing activities

Net (repayments of) / proceeds from borrowings

-7 174

-2 896

Dividends paid

-2 442

-3 013

Share buyback

-

- 362

Payment of lease liabilities

- 610

- 780

Derivative financial instruments

61

- 841

Other financing cash flows

- 455

- 704

Cash flow from/(used in) financing activities

-10 620

-8 596

.

Net increase/(decrease) in cash and cash equivalents

-1 942

315

FY23 recorded an increase in cash and cash equivalents of 315 million USD compared to a decrease of 1 942 million USD in FY22, with the following movements:

Our net debt decreased to 67.6 billion USD as of 31 December 2023 from 69.7 billion USD as of 31 December 2022.

Our net debt to normalized EBITDA ratio was 3.38x as of 31 December 2023. Our optimal capital structure is a net debt to normalized EBITDA ratio of around 2x.

We continue to proactively manage our debt portfolio. After redemptions in December 2023 of 3 billion USD, 98% of our bond portfolio holds a fixed-interest rate, 41% is denominated in currencies other than USD and maturities are well-distributed across the next several years.

In addition to a very comfortable debt maturity profile and strong cash flow generation, as of 31 December 2023, we had total liquidity of 20.5 billion USD, which consisted of 10.1 billion USD available under committed long-term credit facilities and 10.4 billion USD of cash, cash equivalents and short-term investments in debt securities less bank overdrafts.

2024 presentation update

For FY24, the definition of organic revenue growth has been amended to cap the price growth in Argentina to a maximum of 2% per month. Corresponding adjustments will be made to all income statement related items in the organic growth calculations.

Proposed full year 2023 dividend

The AB InBev Board proposes a full year 2023 dividend of 0.82 EUR per share, subject to shareholder approval at the AGM on 24 April 2024. In line with the Company's financial discipline and deleveraging objectives, the recommended dividend balances the Company's capital allocation priorities and dividend policy while returning cash to shareholders. A timeline showing the ex-dividend, record and payment dates can be found below:

Dividend Timeline

Ex-dividend date

Record Date

Payment date

Euronext

3 May 2024

6 May 2024

7 May 2024

MEXBOL

3 May 2024

6 May 2024

7 May 2024

JSE

2 May 2024

6 May 2024

7 May 2024

NYSE (ADR program)

3 May 2024

6 May 2024

7 June 2024

Restricted Shares

3 May 2024

6 May 2024

7 May 2024

Notes

To facilitate the understanding of AB InBev's underlying performance, the analyses of growth, including all comments in this press release, unless otherwise indicated, are based on organic growth and normalized numbers. In other words, financials are analyzed eliminating the impact of changes in currencies on translation of foreign operations, and scope changes. Scope changes represent the impact of acquisitions and divestitures, the start or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. The organic growth of our global brands, Budweiser, Stella Artois, Corona and Michelob Ultra, excludes exports to Australia for which a perpetual license was granted to a third party upon disposal of the Australia operations in 2020. All references per hectoliter (per hl) exclude US non-beer activities. Whenever presented in this document, all performance measures (EBITDA, EBIT, profit, tax rate, EPS) are presented on a "normalized" basis, which means they are presented before non-underlying items. Non-underlying items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as an indicator of the Company's performance. As from 1 January 2023, mark-to-market gains/(losses) on derivatives related to the hedging of our share-based payment programs are reported in the non-underlying net finance income/(cost). The 2022 presentation was amended to conform to the 2023 presentation. We are reporting the results from Argentina applying hyperinflation accounting since 3Q18. The IFRS rules (IAS 29) require us to restate the year-to-date results for the change in the general purchasing power of the local currency, using official indices before converting the local amounts at the closing rate of the period. These impacts are excluded from organic calculations. In FY23, we reported a negative impact on the profit attributable to equity holders of AB InBev of 203 million USD. The impact in FY23 Basic EPS was -0.10 USD. Values in the figures and annexes may not add up, due to rounding. 4Q23 and FY23 EPS is based upon a weighted average of 2 016 million shares compared to a weighted average of 2 013 million shares for 4Q22 and FY22.

Legal disclaimer

This release contains "forward-looking statements". These statements are based on the current expectations and views of future events and developments of the management of AB InBev and are naturally subject to uncertainty and changes in circumstances. The forward-looking statements contained in this release include statements other than historical facts and include statements typically containing words such as "will", "may", "should", "believe", "intends", "expects", "anticipates", "targets", "estimates", "likely", "foresees" and words of similar import. All statements other than statements of historical facts are forward-looking statements. You should not place undue reliance on these forward-looking statements, which reflect the current views of the management of AB InBev, are subject to numerous risks and uncertainties about AB InBev and are dependent on many factors, some of which are outside of AB InBev's control. There are important factors, risks and uncertainties that could cause actual outcomes and results to be materially different, including, but not limited to the risks and uncertainties relating to AB InBev that are described under Item 3.D of AB InBev's Annual Report on Form 20-F filed with the SEC on 17 March 2023. Many of these risks and uncertainties are, and will be, exacerbated by any further worsening of the global business and economic environment, including as a result of the ongoing conflict in Russia and Ukraine and in the Middle East, including the conflict in the Red Sea. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements should be read in conjunction with the other cautionary statements that are included elsewhere, including AB InBev's most recent Form 20-F and other reports furnished on Form 6-K, and any other documents that AB InBev has made public. Any forward-looking statements made in this communication are qualified in their entirety by these cautionary statements and there can be no assurance that the actual results or developments anticipated by AB InBev will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, AB InBev or its business or operations. Except as required by law, AB InBev undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The fourth quarter 2023 (4Q23) and the full year 2023 (FY23) financial data set out in Figure 1 (except for the volume information), Figures 3 to 5, 6, 8, 9, 12 and 13 of this press release have been extracted from the group's audited consolidated financial statements as of and for the twelve months ended 31 December 2023, which have been audited by our statutory auditors PwC Réviseurs d'Entreprises SRL / PwC Bedrijfsrevisoren BV in accordance with the standards of the Public Company Accounting Oversight Board (United States). Financial data included in Figures 7, 10, 11 and 14 have been extracted from the underlying accounting records as of and for the twelve months ended 31 December 2023 (except for the volume information). References in this document to materials on our websites, such as www.ab-inbev.com, are included as an aid to their location and are not incorporated by reference into this document.

Conference call and webcast

Investor Conference call and webcast on Thursday, 29 February 2024:
3.00pm Brussels / 2.00pm London / 9.00am New York

Registration details:
Webcast (listen-only mode):
AB InBev 4Q23 Results Webcast

To join by phone, please use one of the following two phone numbers:
Toll-Free: 877-407-8029
Toll: 201-689-8029

About Anheuser-Busch InBev (AB InBev)

Anheuser-Busch InBev (AB InBev) is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life's moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®, Corona®, Stella Artois® and Michelob Ultra®; multi-country brands Beck's®, Hoegaarden® and Leffe®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 155,000 colleagues based in nearly 50 countries worldwide. For 2023, AB InBev's reported revenue was 59.4 billion USD (excluding JVs and associates).

Annex 1: Segment reporting (4Q)

AB InBev Worldwide

4Q22

Scope

Currency

Translation

Hyperinflation

restatement

Organic

Growth

4Q23

Organic

Growth

Total volumes (thousand hls)

148 775

-151

-

-

-3 919

144 706

-2.6%

of which AB InBev own beer

128 502

-127

-

-

-4 610

123 764

-3.6%

Revenue

14 668

-67

-2 239

1 199

912

14 473

6.2%

Cost of sales

-6 661

22

914

-464

- 491

-6 679

-7.4%

Gross profit

8 007

-44

-1 325

736

421

7 794

5.3%

SG&A

-4 592

13

594

-358

-195

-4 537

-4.3%

Other operating income/(expenses)

193

48

-24

-4

22

234

11.4%

Normalized EBIT

3 608

17

-755

373

248

3 491

6.9%

Normalized EBITDA

4 947

22

-914

518

304

4 877

6.2%

Normalized EBITDA margin

33.7%

33.7%

-2 bps

 

North America

4Q22

Scope

Currency

Translation

Hyperinflation

restatement

Organic

Growth

4Q23

Organic

Growth

Total volumes (thousand hls)

23 451

-149

-

-

-3 563

19 738

-15.3%

Revenue

3 931

-37

2

-

- 613

3 283

-15.7%

Cost of sales

-1 566

21

-

-

103

-1 442

6.6%

Gross profit

2 366

-16

1

-

- 510

1 841

-21.7%

SG&A

-1 166

12

-

-

56

-1 098

4.9%

Other operating income/(expenses)

11

-

-

-

7

18

-

Normalized EBIT

1 211

-4

1

-

-448

761

-37.1%

Normalized EBITDA

1 397

-5

1

-

-436

957

-31.3%

Normalized EBITDA margin

35.5%

29.2%

-660 bps

 

Middle Americas

4Q22

Scope

Currency

Translation

Hyperinflation

restatement

Organic

Growth

4Q23

Organic

Growth

Total volumes (thousand hls)

38 286

-

-

-

348

38 635

0.9%

Revenue

3 913

-17

335

-

206

4 437

5.3%

Cost of sales

-1 521

-7

-128

-

- 76

-1 731

-5.0%

Gross profit

2 392

-23

208

-

130

2 706

5.5%

SG&A

-879

12

-78

-

10

- 934

1.2%

Other operating income/(expenses)

-3

6

-

-

25

27

-

Normalized EBIT

1 510

-5

130

-

165

1 799

11.0%

Normalized EBITDA

1 872

-

160

-

138

2 170

7.4%

Normalized EBITDA margin

47.9%

48.9%

95 bps

 

South America

4Q22

Scope

Currency

Translation

Hyperinflation

restatement

Organic

Growth

4Q23

Organic

Growth

Total volumes (thousand hls)

46 860

-

-

-

- 157

46 704

-0.3%

Revenue

3 380

3

-2 498

1 199

1 001

3 084

29.6%

Cost of sales

-1 661

-1

987

-464

- 312

-1 450

-18.8%

Gross profit

1 718

2

-1 511

736

689

1 635

40.1%

SG&A

-995

-12

673

-358

-197

- 890

-19.6%

Other operating income/(expenses)

97

43

-24

-4

7

119

6.7%

Normalized EBIT

820

34

-862

373

499

863

61.5%

Normalized EBITDA

1 050

34

-1 041

518

545

1 106

52.4%

Normalized EBITDA margin

31.1%

35.8%

541 bps

EMEA

4Q22

Scope

Currency

Translation

Hyperinflation

restatement

Organic

Growth

4Q23

Organic

Growth

Total volumes (thousand hls)

24 094

50

-

-

-180

23 964

-0.7%

Revenue

2 070

20

-82

-

244

2 252

11.7%

Cost of sales

-1 101

-10

57

-

-199

-1 253

-17.9%

Gross profit

969

9

-25

-

46

999

4.7%

SG&A

-636

-14

3

-

-8

- 655

-1.2%

Other operating income/(expenses)

60

-1

1

-

-7

53

-11.1%

Normalized EBIT

393

-6

-21

-

31

397

8.0%

Normalized EBITDA

676

-5

-32

-

37

675

5.5%

Normalized EBITDA margin

32.6%

30.0%

-176 bps

 

Asia Pacific

4Q22

Scope

Currency

Translation

Hyperinflation

restatement

Organic

Growth

4Q23

Organic

Growth

Total volumes (thousand hls)

15 903

-

-

-

-438

15 465

-2.8%

Revenue

1 185

-2

1

-

83

1 267

7.0%

Cost of sales

-624

-

2

-

-16

- 637

-2.5%

Gross profit

561

-2

3

67

630

12.1%

SG&A

-520

1

7

-

-22

- 533

-4.2%

Other operating income/(expenses)

34

-

-1

-

-8

26

-22.7%

Normalized EBIT

76

-1

10

-

38

122

51.3%

Normalized EBITDA

234

-1

6

-

49

288

21.0%

Normalized EBITDA margin

19.8%

22.8%

258 bps

 

Global Export and Holding Companies

4Q22

Scope

Currency

Translation

Hyperinflation

restatement

Organic

Growth

4Q23

Organic

Growth

Total volumes (thousand hls)

181

-52

-

-

71

200

55.0%

Revenue

189

-33

3

-

-9

150

-6.0%

Cost of sales

-189

19

-5

-

9

-166

5.0%

Gross profit

-

-15

-1

-

-1

-17

-4.7%

SG&A

-395

13

-11

-

-34

-427

-8.9%

Other operating income/(expenses)

-6

-

-1

-

-2

-8

-

Normalized EBIT

-401

-1

-13

-

-37

-453

-9.2%

Normalized EBITDA

-282

-1

-8

-

-29

-320

-10.2%

Annex 2: Segment reporting (FY)

AB InBev Worldwide

FY22

Scope

Currency

Translation

Organic

Growth

FY23

Organic

Growth

Total volumes (thousand hls)

595 133

-151

-

-10 255

584 728

-1.7%

of which AB InBev own beer

517 990

- 81

-

-12 010

505 899

-2.3%

Revenue

57 786

-123

-2 744

4 460

59 380

7.8%

Cost of sales

-26 305

45

1 226

-2 362

-27 396

-9.0%

Gross profit

31 481

-78

-1 518

2 099

31 984

6.7%

SG&A

-17 555

-14

696

-1 299

-18 172

-7.4%

Other operating income/(expenses)

841

-146

-43

126

778

19.8%

Normalized EBIT

14 768

-238

-865

925

14 590

6.4%

Normalized EBITDA

19 843

-223

-1 012

1 368

19 976

7.0%

Normalized EBITDA margin

34.3%

33.6%

-23 bps

 

North America

FY22

Scope

Currency

Translation

Organic

Growth

FY23

Organic

Growth

Total volumes (thousand hls)

102 674

-118

-

-12 417

90 140

-12.1%

Revenue

16 566

-36

-80

-1 378

15 072

-8.3%

Cost of sales

-6 714

19

28

151

-6 517

2.2%

Gross profit

9 851

-17

-52

-1 227

8 554

-12.5%

SG&A

-4 587

-18

30

-43

-4 619

-0.9%

Other operating income/(expenses)

45

-

3

-14

34

-30.3%

Normalized EBIT

5 309

-35

-19

-1 285

3 970

-24.4%

Normalized EBITDA

6 057

-37

-24

-1 269

4 727

-21.1%

Normalized EBITDA margin

36.6%

31.4%

-507 bps

 

Middle Americas

FY22

Scope

Currency

Translation

Organic

Growth

FY23

Organic

Growth

Total volumes (thousand hls)

147 624

-

-

1 106

148 730

0.7%

Revenue

14 180

-16

875

1309

16 348

9.2%

Cost of sales

-5 540

-13

-320

-507

-6 379

-9.1%

Gross profit

8 639

-29

556

803

9 969

9.3%

SG&A

-3 390

-6

-228

-167

-3 792

-4.9%

Other operating income/(expenses)

-12

14

2

47

51

-

Normalized EBIT

5 238

-21

329

683

6 228

13.1%

Normalized EBITDA

6 564

-7

430

729

7 715

11.1%

Normalized EBITDA margin

46.3%

47.2%

80 bps

 

South America

FY22

Scope

Currency

Translation

Organic

Growth

FY23

Organic

Growth

Total volumes (thousand hls)

164 319

-

-

-1 859

162 460

-1.1%

Revenue

11 599

4

-2 702

3 139

12 040

27.3%

Cost of sales

-5 976

-1

1 054

-1 062

-5 984

-18.0%

Gross profit

5 623

3

-1 647

2 077

6 056

37.2%

SG&A

-3 458

-28

697

-787

-3 575

-22.8%

Other operating income/(expenses)

473

-153

-38

112

394

40.6%

Normalized EBIT

2 638

-177

-988

1 402

2 875

58.3%

Normalized EBITDA

3 511

-177

-1 137

1 688

3 884

51.9%

Normalized EBITDA margin

30.3%

32.3%

542 bps

EMEA

FY22

Scope

Currency

Translation

Organic

Growth

FY23

Organic

Growth

Total volumes (thousand hls)

90 780

204

-

- 771

90 213

-0.8%

Revenue

8 120

75

-491

885

8 589

10.8%

Cost of sales

-4 167

-40

297

-734

-4 645

-17.5%

Gross profit

3 953

35

-194

150

3 944

3.8%

SG&A

-2 604

-57

105

-58

-2 614

-2.2%

Other operating income/(expenses)

198

-8

-3

12

198

6.2%

Normalized EBIT

1 546

-30

-92

104

1528

6.9%

Normalized EBITDA

2 612

-29

-158

145

2 570

5.6%

Normalized EBITDA margin

32.2%

29.9%

-148 bps

 

Asia Pacific

FY22

Scope

Currency

Translation

Organic

Growth

FY23

Organic

Growth

Total volumes (thousand hls)

88 898

-

-

3 828

92 726

4.3%

Revenue

6 532

-12

-350

655

6 824

10.0%

Cost of sales

-3 168

-1

170

-274

-3 272

-8.6%

Gross profit

3 364

-13

-180

380

3 551

11.4%

SG&A

-2 067

7

105

-178

-2 133

-8.6%

Other operating income/(expenses)

137

-

-7

-17

113

-12.6%

Normalized EBIT

1 433

-6

-82

186

1 531

13.0%

Normalized EBITDA

2 104

-6

-118

206

2 186

9.8%

Normalized EBITDA margin

32.2%

32.0%

-7 bps

 

Global Export and Holding Companies

FY22

Scope

Currency

Translation

Organic

Growth

FY23

Organic

Growth

Total volumes (thousand hls)

838

-236

-

-143

459

-23.7%

Revenue

790

-137

4

-149

508

-22.8%

Cost of sales

-740

80

-3

64

-598

9.8%

Gross profit

50

-57

1

-84

-90

-

SG&A

-1 447

88

-13

-66

-1 439

-4.9%

Other operating income/(expenses)

1

-

-

-14

-13

-

Normalized EBIT

-1 396

32

-12

-165

-1 542

-12.1%

Normalized EBITDA

-1 004

33

-5

-130

-1 106

-13.4%

Annex 3: Consolidated statement of financial position

Million US dollar

31 December 2023

31 December 2022

 

ASSETS

Non-current assets

Property, plant and equipment

26 818

26 671

Goodwill

117 043

113 010

Intangible assets

41 286

40 209

Investments in associates

4 872

4 656

Investment securities

178

175

Deferred tax assets

2 935

2 300

Pensions and similar obligations

12

11

Income tax receivables

844

883

Derivatives

44

60

Trade and other receivables

1 941

1 782

Total non-current assets

195 973

189 757

 

Current assets

Investment securities

67

97

Inventories

5 583

6 612

Income tax receivables

822

813

Derivatives

505

331

Trade and other receivables

6 024

5 330

Cash and cash equivalents

10 332

9 973

Assets classified as held for sale

34

30

Total current assets

23 367

23 186

 

Total assets

219 340

212 943

 

EQUITY AND LIABILITIES

Equity

Issued capital

1 736

1 736

Share premium

17 620

17 620

Reserves

20 276

15 218

Retained earnings

42 215

38 823

Equity attributable to equity holders of AB InBev

81 848

73 398

 

Non-controlling interests

10 828

10 880

Total equity

92 676

84 278

 

Non-current liabilities

Interest-bearing loans and borrowings

74 163

78 880

Pensions and similar obligations

1 673

1 534

Deferred tax liabilities

11 874

11 818

Income tax payables

589

610

Derivatives

151

184

Trade and other payables

738

859

Provisions

320

396

Total non-current liabilities

89 508

94 282

 

Current liabilities

Bank overdrafts

17

83

Interest-bearing loans and borrowings

3 987

1 029

Income tax payables

1 583

1 438

Derivatives

5 318

5 308

Trade and other payables

25 981

26 349

Provisions

269

176

Total current liabilities

37 156

34 383

 

Total equity and liabilities

219 340

212 943

Annex 4: Consolidated statement of cash flows

For the year ended 31 December

Million US dollar

2023

2022

.

OPERATING ACTIVITIES

Profit of the period

6 891

7 597

Depreciation, amortization and impairment

5 411

5 078

Net finance cost/(income)

5 102

4 148

Equity-settled share-based payment expense

570

448

Income tax expense

2 234

1 928

Other non-cash items

1 125

-102

Share of result of associates

-260

844

Cash flow from operating activities before changes in working capital and use of provisions

21 072

19 941

Decrease/(increase) in trade and other receivables

-1 147

-48

Decrease/(increase) in inventories

717

-1 547

Increase/(decrease) in trade and other payables

-1 110

1 249

Pension contributions and use of provisions

-419

-351

Cash generated from operations

19 113

19 244

Interest paid

-3 877

-4 133

Interest received

598

611

Dividends received

127

158

Income tax paid

-2 696

-2 582

Cash flow from/(used in) operating activities

13 265

13 298

.

INVESTING ACTIVITIES

Acquisition of property, plant and equipment and of intangible assets

-4 638

-5 160

Proceeds from sale of property, plant and equipment and of intangible assets

156

322

Sale/(acquisition) of subsidiaries, net of cash disposed/ acquired of

9

-70

Proceeds from sale/(acquisition) of other assets

119

288

Cash flow from/(used in) investing activities

-4 354

-4 620

.

FINANCING ACTIVITIES

Proceeds from borrowings

202

91

Repayments of borrowings

-3 098

-7 265

Dividends paid

-3 013

-2 442

Share buyback

-362

-

Payment of lease liabilities

-780

-610

Derivative financial instruments

-841

61

Sale/(acquisition) of non-controlling interests

-22

-20

Other financing cash flows

-682

-435

Cash flow from/(used in) financing activities

-8 596

-10 620

.

Net increase/(decrease) in cash and cash equivalents

315

-1 942

Cash and cash equivalents less bank overdrafts at beginning of year

9 890

12 043

Effect of exchange rate fluctuations

109

-211

Cash and cash equivalents less bank overdrafts at end of period

10 314

9 890

 

 


These press releases may also interest you

15 avr 2024
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against QuidelOrtho ("QuidelOrtho" or "the Company") and certain of its officers....

15 avr 2024
Tampa General Hospital (TGH) today celebrated more than $120 million in charitable contributions over a two-year period to advance its vision to transform health care through innovation. The latest gift toward the $120 million milestone came from the...

15 avr 2024
The acceleration of digital transformations and cloud implementations by Australian companies and government agencies is expanding the country's Microsoft cloud ecosystem, according to a new research report published today by Information Services...

15 avr 2024
TSX-V:  CWV: Crown Point Energy Inc. ("Crown Point", the "Company", "we" or "our") is pleased to provide an update on the status of its proposed acquisition of a 100% working interest in the Piedra Clavada and Koluel Kaike hydrocarbon exploitation...

15 avr 2024
Acadia Realty Trust (the "Company") announced today that it closed on a $750 million amended and restated credit facility, which replaces and extends the Company's existing $700 million credit facility. The facility was oversubscribed and maintained...

15 avr 2024
Roth CH Acquisition Co. ("we", "us", "our", or the "Company"), today announced that it has notified the Nasdaq Stock Market LLC ("Nasdaq") of its decision to voluntarily delist its Class A Ordinary Shares, Units and Warrants exercisable for one...



News published on and distributed by: